Roc. Oreffo et al., Human bone marrow osteoprogenitors express estrogen receptor-alpha and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation, J CELL BIOC, 75(3), 1999, pp. 382-392
Understanding the mechanisms that control the proliferation and commitment
of human stem cells into cells of the osteogenic lineage for the preservati
on of skeletal structure is of basic importance in bone physiology. This st
udy examines some aspects of the differentiation in vitro of human bone mar
row fibroblastic cells cultured in the absence (basal media) or presence of
1 nM dexamethasone and 50 mu g/ml ascorbate for 6, 10, 14, and 21 days. No
rthern blot analysis and in situ hybridisation with digoxygenin-labelled ri
boprobes for Type I collagen, osteocalcin, bone morphogenetic proteins 2 (B
MP-2), and 4 (BMP-4) and the estrogen receptor alpha (ER alpha), together w
ith immunocytochemical analysis of ER alpha expression and histochemical st
aining of alkaline phosphatase was performed. In basal media, alkaline phos
phatase activity and collagen expressions were detected at day 6, ER alpha
from day 10 and osteocalcin from day 10. In the presence of dexamethasone a
nd ascorbate, cell proliferation and alkaline phosphatase were markedly sti
mulated over 10 to 14 days with a dramatic increase in the temporal express
ion of Type I collagen, ER alpha, and osteocalcin mRNAs in these cultures.
Northern blot analysis showed cells cultured in basal media, expressed the
highest levels of the mRNA for each marker protein at day 14, whereas in th
e presence of ascorbate and dexamethasone, the highest levels for alkaline
phosphatase, ER alpha, osteocalcin, BMP-2, and BMP-4 were observed at day 2
1. ER alpha, BMP-2, and BMP-4 expression were found to correlate temporally
with induction of the osteoblast phenotype as determined by alkaline phosp
hatase, collagen, and osteocalcin expression. These results give additional
information on the development of the osteoblast phenotype from early fibr
oblastic stem cells and on the biological factors involved in this process.
These studies suggest a role for estrogen and BMP-2 and -4 in the differen
tiation of osteoprogenitor cells. J. Cell. Biochem. 75:382-392, 1999. (C) 1
999 Wiley-Liss, Inc.